Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
The Lancet. Global Health
|
August 22, 2021
Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study
Emmy Okello, Emma Ndagire, Babu Muhamed, et al.
Clinical Proteomics
|
March 23, 2022
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases
M Taariq Salie, Jing Yang, Carlos R Ramírez Medina, et al.
JAMA
|
June 5, 2024
Mortality and Morbidity in Adults With Rheumatic Heart Disease
Ganesan Karthikeyan, Mpiko Ntsekhe, Shofiqul Islam, et al.
Circulation. Genomic and Precision Medicine
|
December 22, 2022
Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†
Tafadzwa Machipisa, Chishala Chishala, Gasnat Shaboodien, et al.
JAMA Cardiology
|
June 9, 2021
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals: Findings From the RHDGen Study
Tafadzwa Machipisa, Michael Chong, Babu Muhamed, et al.
American Heart Journal
|
June 1, 2020
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
Ganesan Karthikeyan, Stuart J Connolly, Mpiko Ntsekhe, et al.
The New England Journal of Medicine
|
August 29, 2022
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation
Stuart J Connolly, Ganesan Karthikeyan, Mpiko Ntsekhe, et al.
Cardiovascular Journal of Africa
|
January 28, 2016
Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué
David Watkins, Liesl Zuhlke, Mark Engel, et al.
European Heart Journal
|
November 27, 2014
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)
Liesl Zühlke, Mark E Engel, Ganesan Karthikeyan, et al.
Circulation
|
October 6, 2016
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)
Liesl Zühlke, Ganesan Karthikeyan, Mark E Engel, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
The Lancet. Global Health
|
August 22, 2021
Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study
Emmy Okello, Emma Ndagire, Babu Muhamed, et al.
Clinical Proteomics
|
March 23, 2022
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases
M Taariq Salie, Jing Yang, Carlos R Ramírez Medina, et al.
JAMA
|
June 5, 2024
Mortality and Morbidity in Adults With Rheumatic Heart Disease
Ganesan Karthikeyan, Mpiko Ntsekhe, Shofiqul Islam, et al.
Circulation. Genomic and Precision Medicine
|
December 22, 2022
Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†
Tafadzwa Machipisa, Chishala Chishala, Gasnat Shaboodien, et al.
JAMA Cardiology
|
June 9, 2021
Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals: Findings From the RHDGen Study
Tafadzwa Machipisa, Michael Chong, Babu Muhamed, et al.
American Heart Journal
|
June 1, 2020
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
Ganesan Karthikeyan, Stuart J Connolly, Mpiko Ntsekhe, et al.
The New England Journal of Medicine
|
August 29, 2022
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation
Stuart J Connolly, Ganesan Karthikeyan, Mpiko Ntsekhe, et al.
Cardiovascular Journal of Africa
|
January 28, 2016
Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué
David Watkins, Liesl Zuhlke, Mark Engel, et al.
European Heart Journal
|
November 27, 2014
Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study)
Liesl Zühlke, Mark E Engel, Ganesan Karthikeyan, et al.
Circulation
|
October 6, 2016
Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)
Liesl Zühlke, Ganesan Karthikeyan, Mark E Engel, et al.
Page
of 8